Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vitaly Kochin

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunityVitaly Kochin, Hiroyoshi Nishikawa
Nucleus (Austin, Tex.)|March 21, 2015
Phosphorylation of lamins determine their structural properties and signaling functionsElin Torvaldson, Vitaly Kochin, John E Eriksson
Proteomics|October 7, 2006
Fast track to a phosphoprotein sketch - MALDI-TOF characterization of TLC-based tryptic phosphopeptide maps at femtomolar detection sensitivityVitaly Kochin, Susumu Y Imanishi, John E Eriksson
Proteomics|December 8, 2006
Optimization of phosphopeptide elution conditions in immobilized Fe(III) affinity chromatographySusumu Y Imanishi, Vitaly Kochin, John E Eriksson
Methods in Cell Biology|January 14, 2005
Approaches to study posttranslational regulation of intermediate filament proteinsVitaly Kochin, Hanna-Mari Pallari, Harish Pant, et al.
FEBS Letters|May 27, 2008
Providing cellular signposts--post-translational modifications of intermediate filamentsClaire L Hyder, Hanna-Mari Pallari, Vitaly Kochin, et al.
Oncoimmunology|July 9, 2015
HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancerYoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The path to innovative drug development of cancer vaccine: from discovery of tumor antigens to clinical trials]Toshihiko Torigoe, Yoshihiko Hirohashi, Tomohide Tsukahara, et al.
Cancer Science|October 7, 2015
Immune responses to human cancer stem-like cells/cancer-initiating cellsYoshihiko Hirohashi, Toshihiko Torigoe, Tomohide Tsukahara, et al.
Immunotherapy|June 4, 2013
Cytotoxic T lymphocytes: the future of cancer stem cell eradication?Hiroshi Saijo, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunityVitaly Kochin, Hiroyoshi Nishikawa
Nucleus (Austin, Tex.)|March 21, 2015
Phosphorylation of lamins determine their structural properties and signaling functionsElin Torvaldson, Vitaly Kochin, John E Eriksson
Proteomics|October 7, 2006
Fast track to a phosphoprotein sketch - MALDI-TOF characterization of TLC-based tryptic phosphopeptide maps at femtomolar detection sensitivityVitaly Kochin, Susumu Y Imanishi, John E Eriksson
Proteomics|December 8, 2006
Optimization of phosphopeptide elution conditions in immobilized Fe(III) affinity chromatographySusumu Y Imanishi, Vitaly Kochin, John E Eriksson
Methods in Cell Biology|January 14, 2005
Approaches to study posttranslational regulation of intermediate filament proteinsVitaly Kochin, Hanna-Mari Pallari, Harish Pant, et al.
FEBS Letters|May 27, 2008
Providing cellular signposts--post-translational modifications of intermediate filamentsClaire L Hyder, Hanna-Mari Pallari, Vitaly Kochin, et al.
Oncoimmunology|July 9, 2015
HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancerYoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The path to innovative drug development of cancer vaccine: from discovery of tumor antigens to clinical trials]Toshihiko Torigoe, Yoshihiko Hirohashi, Tomohide Tsukahara, et al.
Cancer Science|October 7, 2015
Immune responses to human cancer stem-like cells/cancer-initiating cellsYoshihiko Hirohashi, Toshihiko Torigoe, Tomohide Tsukahara, et al.
Immunotherapy|June 4, 2013
Cytotoxic T lymphocytes: the future of cancer stem cell eradication?Hiroshi Saijo, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Pageof 4